News & Topics

Research
2021.08.19

A sublethal ATP11A mutation causes aberrant phosphatidylcholine flipping in plasma membranes (Nagata G, in JCI)

PRESS RELEASE

Shigekazu Nagata (Biochemistry & Immunology, IFReC), Katsumori Segawa (present: TMDU) and the research group detected a de novo heterozygous point mutation in ATP11A in a patient with developmental delays and neurological deterioration.

figure

Commentary (PDF)


Article (External Link)


Contact:
Shigekazu Nagata

Shigekazu Nagata (Biochemistry & Immunology)


Tel+81-6-6879-4953
Mail snagataifrec.osaka-u.ac.jp

Immunology Frontier Research Center, Osaka University (WPI-IFReC)